© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
CAR T-Cell Therapy for the Management of Multiple Myeloma
January 25, 2021
Oncologists explore the opportunity of CAR T-cell therapy for the treatment of relapsed/refractory multiple myeloma.